The first patient has been dosed in a clinical trial testing Sardocor's one-time gene therapy for cardiomyopathy associated ...

Dealing with pain has become increasingly challenging for columnist Robin Stemple, who struggles to find relief from the hurt ...

Capricor plans to resubmit its application for the approval of deramiocel for DMD after the FDA declined to accept the ...

Columnist Shalom Lim is energized by a recent program for youth leaders in Singapore that matched them with people from the ...

Households incur substantial costs to accommodate Duchenne muscular dystrophy (DMD) patients, according to a survey of U.S.

We all have different tolerance levels for how much risk we'll accept when we do a risk vs. reward analysis, says columnist.

A research team collected pain and prescription data from the medical records of 1,282 people with different types of ...

Researchers identified a unique protein signature in the blood of BMD and LGMD patients that may reflect disease progression.

Columnist Betty Vertin embraces July's slower pace, a much-needed respite from caregiving demands for her family of nine.

Doctors can use several tests to diagnose muscular dystrophy (MD). A correct diagnosis gives patients an understanding of how their disease is likely to progress. It also helps doctors do a better job ...

The CRISPR/Cas9 method for genome editing is a powerful new technology with many applications in biomedical research, including the potential to treat DMD.

Different types of muscular dystrophy (MD) may affect different muscle groups. Patients often have difficulty walking and may have problems with muscle control in other tasks, such as dressing or ...